Jasper Therapeutics (JSPR) Q2 2025 Earnings

12MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-1.62
-1.4
-1.19
-0.97

Details

Expected EPS
-1.347613
Actual EPS
-1.41
Surprise EPS
-0.06
Surprise Percent
+4.63%

Description

Jasper Therapeutics (JSPR) has reported earnings of -1.41 per share for Q2 2025.

0 Comments

Share your thoughts